drugset / Trial / NCT03933618

Anastrazole and Clomiphene to Evaluate Hypogonadal Symptoms and Erectile Function

NCT03933618

RandomizedCrossoverTriple-blindTreatment

Summary

This study evaluates anastrazole and clomiphene in the improvement in hypogonadal symptoms and erectile function. Each subject will receive Anastrazole 1 mg/day, clomiphene 25 mg/day and placebo in randomized schedule of 8 week intervals.

Timeline

Start
2015-04-02
Primary completion
2017-03-08
Completion
2017-03-08

Drugs

EvaluationDrugModalityDoseRoute
Subject Anastrozole Other / unclassified 1 mg
Subject Clomiphene Other / unclassified 25 mg

Indications